Dr. Sehnert is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
331 Panorama Drive
San Francisco, CA 94131Phone+1 415-297-6428- Is this information wrong?
Education & Training
University of California (San Francisco)Fellowship, Pediatric Cardiology, 1995 - 1999
University of ColoradoResidency, Pediatrics, 1992 - 1995
University of Minnesota Medical SchoolClass of 1992
Certifications & Licensure
CA State Medical License 1995 - 2025
Clinical Trials
- Genetic Substudy of the Alternans Before Cardioverter Defibrillator (ABCD) Trial Start of enrollment: 2007 Jan 01
- MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy Start of enrollment: 2010 Jun 01
- Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Start of enrollment: 2018 May 29
- Join now to see all
Publications & Presentations
PubMed
- Patient-Level Artificial Intelligence-Enhanced Electrocardiography in Hypertrophic Cardiomyopathy: Longitudinal Treatment and Clinical Biomarker Correlations.Siontis, K., Abreau, S., Attia, Z., Barrios, J., Dewland, T., Agarwal, P., Balasubramanyam, A., Li, Y., Lester, S., Masri, A., Wang, A., Sehnert, A., Edelberg, J., Abr...> ;JACC. Advances. 2023 Oct 1
- 10 citationsEffect of beta-blocker therapy on the response to mavacamten in patients with symptomatic obstructive hypertrophic cardiomyopathy.Matthew T Wheeler, Daniel Jacoby, Perry M Elliott, Sara Saberi, Sheila M Hegde, Neal K Lakdawala, Jonathan Myers, Amy J Sehnert, Jay M Edelberg, Wanying Li, Iacopo Oli...> ;European Journal of Heart Failure. 2023 Feb 1
- 10 citationsEffects of Mavacamten on Measures of Cardiopulmonary Exercise Testing Beyond Peak Oxygen Consumption: A Secondary Analysis of the EXPLORER-HCM Randomized Trial.Matthew T Wheeler, Iacopo Olivotto, Perry M Elliott, Sara Saberi, Anjali T Owens, Mathew S Maurer, Ahmad Masri, Amy J Sehnert, Jay M Edelberg, Yu-Mao Chen, Victoria Fl...> ;JAMA Cardiology. 2023 Mar 1
- Join now to see all
Press Mentions
- Using AI in Electrocardiogram Analysis Can Improve Diagnosis and Treatment of Hypertrophic CardiomyopathyMarch 7th, 2022
- Results from Two Phase 3 Studies Evaluating Mavacamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy ReleasedSeptember 10th, 2023
- Results from Two Phase 3 Studies Evaluating CAMZYOS (Mavacamten) for Symptomatic Obstructive Hypertrophic Cardiomyopathy (HCM) Released by Bristol Myers SquibbSeptember 6th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
